广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2024-06-30 | GILD | 吉利德科学 | 买入 | 233.45 | 1.59% |
| 2024-06-30 | VRTX | 福泰制药 | 卖出 | 219.17 | 1.5% |
| 2024-06-30 | KRTX | Karuna Therapeutics Inc | 卖出 | 168.79 | 1.15% |
| 2024-06-30 | REGN | 再生元制药 | 卖出 | 129.25 | 0.88% |
| 2024-06-30 | IMGN | ImmunoGen Inc | 卖出 | 113.54 | 0.78% |
| 2024-06-30 | AMGN | 安进 | 卖出 | 105.38 | 0.72% |
| 2024-06-30 | AZN | 阿斯利康(US ADR) | 卖出 | 79.9 | 0.55% |
| 2024-06-30 | ALPN US | Alpine Immune Sciences Inc | 卖出 | 57.2 | 0.39% |
| 2024-06-30 | MRTX | Mirati Therapeutics Inc | 卖出 | 55.22 | 0.38% |
| 2024-06-30 | CBAY | CymaBay Therapeutics Inc | 卖出 | 49.94 | 0.34% |
| 2024-06-30 | AMGN | 安进 | 买入 | 28.65 | 0.2% |
| 2024-06-30 | DCPH | Deciphera Pharmaceuticals Inc | 卖出 | 27.88 | 0.19% |
| 2024-06-30 | INBX | Inhibrx Biosciences Inc | 卖出 | 24.12 | 0.16% |
| 2024-06-30 | AMAM US | Ambrx Biopharma Inc | 卖出 | 23.97 | 0.16% |
| 2024-06-30 | FUSN US | Fusion Pharmaceuticals Inc | 卖出 | 19.86 | 0.14% |
| 2024-06-30 | INSM | Insmed Inc | 买入 | 20.1 | 0.14% |
| 2024-06-30 | DYN | Dyne Therapeutics Inc | 买入 | 16.4 | 0.11% |
| 2024-06-30 | CYTK | Cytokinetics Inc | 买入 | 14.44 | 0.1% |
| 2024-06-30 | ALNY | Alnylam Pharmaceuticals Inc | 买入 | 14.97 | 0.1% |
| 2024-06-30 | BIIB | 生化基因 | 买入 | 14.71 | 0.1% |
公告&资料
